Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Apomorphine (APO-go®)		Amber - specialist recommendation
Apomorphine (Dacepton®)		Specialist recommendation - solution for injection in cartridge
Apraclonidine 1% eye drops (preserv-free)		Only PF sympathomimetic
Aripiprazole tablets	TA213 - Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years TA292 - Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder	Supported by ESCA. The GP should be given a rationale for prescribing rather than first line antipsychotics. Approved for use in Tourette's Syndrome.
Asacol M/R 400mg, 800mg
Atomoxetine		ESCAs and additional advice in relation to age of patient and CCG
Atropine 1% drops
Atropine SF solution
Atropine sulphate 0.5% drops
Atropine suplhate 1% single use drops		Specialist ophthalmologist recommendation

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.